Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)
Clinical trial NCT06823960 · RECRUITING
Trial details
- NCT number
- NCT06823960
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-09
- Primary completion
- 2025-06-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.